Millennium Management LLC lifted its stake in Accuray Incorporated (NASDAQ:ARAY) by 59.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,257,268 shares of the medical equipment provider’s stock after purchasing an additional 470,087 shares during the quarter. Millennium Management LLC’s holdings in Accuray were worth $4,287,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the company. Macquarie Group Ltd. lifted its stake in shares of Accuray by 46.7% in the 4th quarter. Macquarie Group Ltd. now owns 7,810 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 2,487 shares during the period. MetLife Investment Advisors LLC lifted its stake in shares of Accuray by 34.8% in the 4th quarter. MetLife Investment Advisors LLC now owns 42,251 shares of the medical equipment provider’s stock worth $144,000 after acquiring an additional 10,915 shares during the period. Candriam Luxembourg S.C.A. raised its holdings in shares of Accuray by 18.4% in the 4th quarter. Candriam Luxembourg S.C.A. now owns 82,853 shares of the medical equipment provider’s stock worth $283,000 after purchasing an additional 12,853 shares in the last quarter. Two Sigma Advisers LP raised its holdings in shares of Accuray by 10.6% in the 4th quarter. Two Sigma Advisers LP now owns 139,719 shares of the medical equipment provider’s stock worth $476,000 after purchasing an additional 13,389 shares in the last quarter. Finally, Algert Global LLC raised its holdings in shares of Accuray by 3.0% in the 4th quarter. Algert Global LLC now owns 459,868 shares of the medical equipment provider’s stock worth $1,568,000 after purchasing an additional 13,474 shares in the last quarter. 80.24% of the stock is owned by institutional investors.
In related news, CEO Joshua Levine sold 6,604 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $4.54, for a total value of $29,982.16. Following the sale, the chief executive officer now directly owns 1,033,593 shares in the company, valued at approximately $4,692,512.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.40% of the stock is owned by insiders.
Accuray (NASDAQ:ARAY) last released its earnings results on Tuesday, January 22nd. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Accuray had a negative net margin of 5.74% and a negative return on equity of 42.74%. The business had revenue of $102.32 million for the quarter, compared to the consensus estimate of $104.01 million. During the same period in the previous year, the firm earned ($0.06) EPS. On average, equities analysts predict that Accuray Incorporated will post -0.16 earnings per share for the current year.
ARAY has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Accuray from a “hold” rating to a “buy” rating and set a $5.50 target price on the stock in a report on Thursday, February 14th. BidaskClub downgraded shares of Accuray from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. Accuray presently has a consensus rating of “Hold” and an average target price of $5.13.
COPYRIGHT VIOLATION NOTICE: “Accuray Incorporated (ARAY) Shares Bought by Millennium Management LLC” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2019/04/17/accuray-incorporated-aray-shares-bought-by-millennium-management-llc.html.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.
Further Reading: How do taxes affect a CDs total return?
Want to see what other hedge funds are holding ARAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accuray Incorporated (NASDAQ:ARAY).
Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter.